14 completed, 6 unknown, 1 not yet recruiting, 1 terminated. 22 Phase 2, 6 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 22 | Completed 14, Unknown 6, Not yet recruiting 1, Terminated 1 |
| Phase 3 | 6 | Unknown 4, Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Levosimendan: new trials by email Literature Review of Levosimendan trials Research Report on Levosimendan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levosimendan in Acute Decompensated Heart Failure Levosimendan, Standard care - Acute Decompensated Heart Failure (ADHF) | Phase 2 / Phase 3 | Not yet recruiting | Chittagong Medical College | 332 | 2025-12-01 | 2025-12-04 |
| Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage Levosimendan, Placebo - Sub-arachnoid Haemorrhage | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 30 | 2023-10-13 | 2026-08-31 |
| Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV levosimendan, 5% glucose injection - Transesophageal Echocardiography, Acute Respiratory Distress Syndrome | Phase 2 / Phase 3 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 58 | 2023-03-22 | 2023-03-14 |
| Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery Levosimendan, Standard Care - Right Heart Failure, Open-heart Surgery | Phase 2 | Unknown | Ain Shams University | 40 | 2021-08-18 | 2021-10-20 |
| Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS) Levosimendan, Placebos - Cardiac Output, Low | Phase 2 / Phase 3 | Unknown | María de los Ángeles Tena Pajuelo | 300 | 2020-06-17 | 2020-07-24 |
| Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients Levosimendan - Hypertension Pulmonary Secondary Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction | Phase 2 | Completed | Tenax Therapeutics, Inc. | 35 | 2019-04-09 | 2026-04-22 |
| Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF Levosimendan, Matching Placebo - Hypertension Pulmonary Secondary, Heart Failure, Right Sided | Phase 2 | Completed | Tenax Therapeutics, Inc. | 44 | 2018-11-14 | 2024-11-20 |
| Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries Levosimendan, Saline - Heart Failure | Phase 2 | Completed | National Cancer Institute, Egypt | 60 | 2017-08-01 | 2018-06-14 |
| Levosimendan in Acute Kidney Injury Study Levosimendan, Conventional therapy - Acute Kidney Injury | Phase 2 / Phase 3 | Completed | VieCuri Medical Centre | 68 | 2016-09-01 | 2026-08-21 |
| Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis ODM-109, Placebo for ODM-109 - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | Orion Corporation, Orion Pharma | 66 | 2015-07-01 | 2017-11-28 |
| Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease? Levosimendan, Milrinone - Congenital Heart Defects | Phase 2 | Completed | Göteborg University | 72 | 2014-10-15 | 2024-03-26 |
| Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients Levosimendan, Placebo - Muscle Weakness Conditions, Weaning Failure | Phase 2 / Phase 3 | Unknown | University Medical Center Nijmegen | 42 | 2012-09-01 | 2015-06-10 |
| Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children Levosimendan, Conventional intensified inotropic treatment - Acute Heart Failure | Phase 2 | Terminated | Jose Luis Vazquez Martinez | 116 | 2011-02-01 | 2013-01-31 |
| Two Inodilators Postsurgery in Neonates Milrinone, Levosimendan - Low Cardiac Output Syndrome | Phase 1 / Phase 2 | Completed | Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | 20 | 2009-11-01 | 2012-04-12 |
| Levosimendan Administration in Neonates With Transposition of the Great Arteries levosimendan, placebo - Low Cardiac Output Syndrome | Phase 2 | Completed | Bambino Gesù Hospital and Research Institute | 63 | 2009-01-01 | 2012-06-26 |
| Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables Levosimendan, Placebo - Transient Ischemic Attack, Stroke | Phase 2 | Completed | Orion Corporation, Orion Pharma | 32 | 2008-08-01 | 2009-11-25 |
| Effects of Levosimendan on Microcirculation in Septic Shock Levosimendan, dobutamine - Septic Shock | Phase 2 | Completed | University of Roma La Sapienza | 40 | 2007-11-01 | 2009-10-15 |
| Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants Levosimendan, Milrinone - Low Cardiac Output Syndrome | Phase 2 | Unknown | Ludwig Boltzmann Gesellschaft | 40 | 2007-09-01 | 2007-10-25 |
| Myocardial Hemodynamic Effects of Levosimendan levosimendan - Heart Failure | Phase 2 | Completed | University of Utah | 10 | 2006-09-01 | 2013-05-21 |
| Peroral Levosimendan in Chronic Heart Failure levosimendan - Chronic Heart Failure, Heart Diseases | Phase 2 | Completed | Orion Corporation, Orion Pharma | 300 | 2005-03-01 | 2007-02-21 |
Showing 20 of 22. Sign in to see all of them.
Heart Failure (5) · Cardiac Output, Low (4) · Heart Defects, Congenital (2) · Sepsis (2) · Shock, Septic (2) · Stroke (2) · Acute Kidney Injury (1) · Amyotrophic Lateral Sclerosis (1) · Coronary Disease (1) · Heart Diseases (1) · Ischemic Attack, Transient (1) · Respiratory Distress Syndrome (1) · Shock (1) · Shock, Cardiogenic (1) · Transposition of Great Vessels (1)
Orion Corporation, Orion Pharma (4) · Tenax Therapeutics, Inc. (2) · Ain Shams University (1) · Assistance Publique - Hôpitaux de Paris (1) · Bambino Gesù Hospital and Research Institute (1) · Chittagong Medical College (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz (1) · Göteborg University (1) · Jose Luis Vazquez Martinez (1) · Ludwig Boltzmann Gesellschaft (1) · María de los Ángeles Tena Pajuelo (1) · National Cancer Institute, Egypt (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · University Medical Center Nijmegen (1) · University of Roma La Sapienza (1)
Finland (4) · Netherlands (3) · Spain (3) · United States (3) · Egypt (2) · Germany (2) · Italy (2) · Sweden (2) · Australia (1) · Austria (1) · Bangladesh (1) · China (1) · France (1) · Hungary (1) · Ireland (1)
Adelina Pellicer, PhD (1) · Albert Castellheim, MD, PhD (1) · Andrea Morelli, M.D. (1) · Andrew Michaels, MD (1) · Anna Hofer, MD (1) · Benjamin Glen Chousterman (1) · Birgitta Romlin, MD, PhD (1) · Carlos Labrandero, MD (1) · Ehab H Shaker, MD (1) · Elin Thorlacius, MD (1) · Elisabet B Berastegui Garcia, Cardiac surgery (1) · Evelyn Lechner, MD (1)
PMID 12947373, PMID 15475828, PMID 16181823, PMID 17086092, PMID 17566702, PMID 18297097, PMID 19700350, PMID 21182783, PMID 21784540, PMID 23620700, PMID 24126568, PMID 24614322, PMID 26082815, PMID 28416392, PMID 29718383, PMID 31315908, PMID 33739957, PMID 33839076, PMID 34716759
2009 (1), 2019 (1)